Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Chronic Myeloid Leukaemia: A Guide for Patients

ESMO-Patient-Guides-Chronic-Myeloid-Leukaemia-1000x250

Guides for Patients are designed to assist patients, their relatives and caregivers to better understand the nature of different types of cancer and evaluate the best available treatment choices.

Definition of chronic myeloid leukaemia (CML)

There are different forms of leukaemia depending on what type of blood cell is affected. “Chronic” describes a slow progression, and “myeloid” denotes the origin from myeloid cells - immature cells that normally become mature red blood cells, white blood cells, or platelets. In chronic myeloid leukaemia, the bone marrow produces too many myeloid blood cells at various stages of maturation. Excess production of myleloid blood cells in the bone marrow ultimately prevents the normal production of red blood cells, and decreased production of platelets.

Beyond a definition of chronic myeloid leukaemia, in this guide for patients you will also find answers to questions such as:

  • Is chronic myeloid leukaemia frequent?
  • What causes chronic myeloid leukaemia?
  • How is chronic myeloid leukaemia diagnosed?
  • What is it important to know to get the optimal treatment?
  • What are the treatment options?
  • What happens after the treatment?

This guide for patients has been prepared in collaboration with Anti-Cancer Fund as a service to patients, to help patients and their relatives better understand the nature of Chronic Myeloid Leukaemia and appreciate the best treatment choices available according to the subtype of Chronic Myeloid Leukaemia. ESMO recommends that patients ask their doctors about what tests or types of treatments are needed for their type and stage of disease.

Patient Guides for Chronic Myeloid Leukaemia were published in 2013.

To enquire about permission to translate or support the distribution (in English or in a translated version) of the Patient Guides series, please send an e-mail to patient_guides@esmo.org

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings